tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
GoodRx price target lowered to $4 from $4.75 at BofA
PremiumThe FlyGoodRx price target lowered to $4 from $4.75 at BofA
3M ago
Strong Q1 2025 Performance and Raised EBITDA Guidance Justify Buy Rating for GoodRx Holdings
Premium
Ratings
Strong Q1 2025 Performance and Raised EBITDA Guidance Justify Buy Rating for GoodRx Holdings
3M ago
GoodRx Holdings Faces Sell Rating Amid Decline in Consumer Growth and Cautious Revenue Outlook
Premium
Ratings
GoodRx Holdings Faces Sell Rating Amid Decline in Consumer Growth and Cautious Revenue Outlook
3M ago
GoodRx price target lowered to $7 from $8 at Wells Fargo
PremiumThe FlyGoodRx price target lowered to $7 from $8 at Wells Fargo
3M ago
GoodRx Holdings: Strategic Positioning and Cost Advantages Support Buy Rating Amidst Competitive Landscape
Premium
Ratings
GoodRx Holdings: Strategic Positioning and Cost Advantages Support Buy Rating Amidst Competitive Landscape
3M ago
GoodRx price target lowered to $5.50 from $6.50 at Truist
Premium
The Fly
GoodRx price target lowered to $5.50 from $6.50 at Truist
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100